BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARD
3576
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $11.6M | ﹤0.01% |
456,390
+15,021
| +3% | +$377K |
|
|
EH
3577
EHang Holdings
EH
$442M
| $11.6M | ﹤0.01% |
483,875
+59,704
| +14% | +$1.63M |
|
|
GOCO
3578
DELISTED
GoHealth
GOCO
| $11.6M | ﹤0.01% |
153,289
+16,908
| +12% | +$1.79M |
|
3579
Mayville Engineering Co
MEC
$597M
| $11.5M | ﹤0.01% |
612,590
-789
| -0.1% | -$13.5K |
|
|
XOMA
3580
DELISTED
Xoma
XOMA
| $11.5M | ﹤0.01% |
463,796
+8,335
| +2% | +$246K |
|
3581
Telkom Indonesia
TLK
$14.5B
| $11.5M | ﹤0.01% |
451,289
+72,464
| +19% | +$1.67M |
|
3582
Mizuho Financial
MFG
$134B
| $11.4M | ﹤0.01% |
4,009,978
+301,112
| +8% | +$868K |
|
3583
Fidelity D&D Bancorp
FDBC
$321M
| $11.4M | ﹤0.01% |
225,490
-681
| -0.3% | -$35.8K |
|
|
FOVL
3584
DELISTED
iShares Focused Value Factor ETF
FOVL
| $11.4M | ﹤0.01% |
207,000
| – | – |
|
3585
ICL Group
ICL
$6.96B
| $11.3M | ﹤0.01% |
1,561,074
+201,858
| +15% | +$1.43M |
|
|
SCHV
3586
Schwab US Large-Cap Value ETF
SCHV
$16.3B
| $11.3M | ﹤0.01% |
502,233
-15,099
| -3% | -$349K |
|
3587
Biomea Fusion
BMEA
$92.8M
| $11.2M | ﹤0.01% |
939,741
-161,948
| -15% | -$2.06M |
|
|
MILE
3588
DELISTED
Metromile, Inc. Common Stock
MILE
| $11.2M | ﹤0.01% |
3,166,864
+111,780
| +4% | +$631K |
|
|
AFIB
3589
DELISTED
Acutus Medical Inc
AFIB
| $11.2M | ﹤0.01% |
1,271,601
+200,749
| +19% | +$2.64M |
|
3590
Schwab Fundamental International Large Company Index ETF
FNDF
$25.8B
| $11.2M | ﹤0.01% |
342,015
-3,762
| -1% | -$125K |
|
3591
The ONE Group
STKS
$56.8M
| $11.2M | ﹤0.01% |
1,044,512
+52,869
| +5% | +$545K |
|
|
RPTX
3592
DELISTED
Repare Therapeutics
RPTX
| $11.2M | ﹤0.01% |
425,037
+12,589
| +3% | +$407K |
|
3593
Immunic
IMUX
$226M
| $11.1M | ﹤0.01% |
125,115
+12,486
| +11% | +$1.23M |
|
|
AMAM
3594
DELISTED
Ambrx Biopharma Inc
AMAM
| $11.1M | ﹤0.01% |
820,221
-30,455
| -4% | -$548K |
|
3595
Vanguard Total International Bond ETF
BNDX
$83B
| $11.1M | ﹤0.01% |
194,292
-47
| -0% | -$2.71K |
|
|
TARO
3596
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $11M | ﹤0.01% |
173,653
+5,323
| +3% | +$368K |
|
|
NGAB.U
3597
DELISTED
Northern Genesis Acquisition Corp. II Units, each consisting of one share of common stock and one-th
NGAB.U
| $11M | ﹤0.01% |
1,075,904
-16,852
| -2% | -$174K |
|
3598
CALL
Liberty Global Class C
LBTYK
$3.48B
| $11M | ﹤0.01% |
+370,000
| New | +$10.3M |
|
3599
Nature's Sunshine
NATR
$269M
| $11M | ﹤0.01% |
749,817
+43,106
| +6% | +$724K |
|
3600
Solid Biosciences
SLDB
$974M
| $10.8M | ﹤0.01% |
300,780
+29,531
| +11% | +$1.25M |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.